-
233%
CD34 AND CD3 CELL COUNT – ...
Enumeration of viable CD34 positive stem cells according to ISHAGE guidelines. Single platform method.CD34 AND CD3 CELL COUNT – ...
Enumeration of viable CD34 positive stem cells according to ISHAGE guidelines. Single platform method. -
233%
CD34 Count
Enumeration of viable CD34 positive stem cells according to ISHAGE guidelines. Single platform method.CD34 Count
Enumeration of viable CD34 positive stem cells according to ISHAGE guidelines. Single platform method. - 233%
-
233%
CD4/CD8 Count
Reflection of immune system health -
238%
CLPD panel-1 CD5,,CD23,CD19,CD ...
Kappa,Lamda,CD38,19,45,5,10,20,3,4,5,7,56,200,23,43,49d,FMC-7, Additiional CD103,123,25,11cCLPD panel-1 CD5,,CD23,CD19,CD ...
Kappa,Lamda,CD38,19,45,5,10,20,3,4,5,7,56,200,23,43,49d,FMC-7, Additiional CD103,123,25,11c -
238%
CLPD Panel-CD5,CD23,CD19,CD3,C ...
B/T CLPD evaluation -
259%
HLA B27 by PCR
NIL -
259%
HLA B27-Flow Cytometry
HLA B 27 autoimmune disorders -
260%
Immunophenotyping Minimal Resi ...
Detection of Minimal Residual Disease (MRD)
